Windlas Biotech Ltd (WINDLAS) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 1003519, "name": "Windlas Biotech", "stock_name": "Windlas Biotech", "full_name": "Windlas Biotech Ltd", "name_url": "stocks-analysis/windlas-biotech", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "869.35", "chg": 17.3, "chgp": "2.03%", "dir": 1, "prev_price": "852.05", "mcapval": "1,794.01 Cr", "mcap": "Small Cap", "scripcode": 543329, "symbol": "WINDLAS", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE0H5O01029", "curr_date": "Aug 06, 10:12 AM", "curr_time": "10:14 AM", "last_traded_at": "Aug 06, 10:12 AM IST", "bse_nse_vol": "4.73 k", "exc_status": "Active", "traded_date": "Aug 06, 2026", "traded_date_str": "2026 08 06", "score": "", "scoreText": "", "Live": 1, "market_time": 1, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/windlas-biotech-1003519-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "When is the next results date for Windlas Biotech Ltd?", "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-windlas-biotech-ltd-4138831", "imagepath": "", "date": "2026-08-05 23:20:27", "description": "The next results date for Windlas Biotech Ltd is scheduled for 10 August 2026...." }, { "title": "Windlas Biotech Valuation Shifts to Fair Amidst Sector Comparisons", "link": "https://www.marketsmojo.com/news/stocks-in-action/windlas-biotech-valuation-shifts-to-fair-amidst-sector-comparisons-4136958", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/WindlasBiotechL_valuationdot_4136958.png", "date": "2026-08-05 08:03:37", "description": "Windlas Biotech Ltd has seen a notable change in its valuation parameters, moving from an attractive to a fair rating as of mid-2026. This shift reflects evolving market perceptions amid a competitive pharmaceuticals and biotechnology sector, where peers continue to command premium multiples. Investors are advised to consider these valuation dynamics alongside the company’s operational metrics and broader market trends." }, { "title": "Windlas Biotech Ltd is Rated Hold by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/windlas-biotech-ltd-is-rated-hold-by-marketsmojo-4122514", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/WindlasBiotechL_mojoScore_4122514.png", "date": "2026-07-27 10:10:04", "description": "Windlas Biotech Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 15 July 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 27 July 2026, providing investors with the latest insights into the company’s performance and outlook." }, { "title": "Windlas Biotech Gains 1.81%: 3 Key Technical Signals Driving the Week", "link": "https://www.marketsmojo.com/news/stocks-in-action/windlas-biotech-gains-181-3-key-technical-signals-driving-the-week-4107194", "imagepath": "", "date": "2026-07-18 11:02:57", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>13 Jul:</strong> Stock opens strong at Rs.852.10 (+2.69%)</p>\n <p><strong>15 Jul:</strong> Golden Cross formation signals potential bullish breakout</p>\n <p><strong>16 Jul:</strong> Mojo Grade upgraded to Hold amid improving technicals</p>\n <p><strong>17 Jul:</strong> Week closes at Rs.844.80 (-0.56%)</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.829.80</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.844.80</div><div class=..." }, { "title": "Windlas Biotech Upgraded to Hold as Technicals Improve Amid Mixed Financials", "link": "https://www.marketsmojo.com/news/stock-recommendation/windlas-biotech-upgraded-to-hold-as-technicals-improve-amid-mixed-financials-4104596", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/WindlasBiotechL_mojoScore_4104596.png", "date": "2026-07-16 08:23:24", "description": "Windlas Biotech Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Sell to Hold as of 15 July 2026. This change reflects a nuanced improvement across technical indicators, valuation metrics, and financial trends, despite some lingering concerns over flat quarterly performance and modest long-term growth. The company’s current Mojo Score stands at 58.0, signalling a cautious but more optimistic outlook for investors." }, { "title": "Windlas Biotech Ltd Technical Momentum Shifts to Mildly Bullish Amid Mixed Indicators", "link": "https://www.marketsmojo.com/news/stocks-in-action/windlas-biotech-ltd-technical-momentum-shifts-to-mildly-bullish-amid-mixed-indicators-4104489", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/WindlasBiotechL_technicaldot_4104489.png", "date": "2026-07-16 08:03:43", "description": "Windlas Biotech Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a mildly bullish outlook. This change is underscored by a combination of technical indicators, including MACD, RSI, moving averages, and Bollinger Bands, which collectively suggest a cautious but improving trend for the pharmaceutical and biotechnology small-cap stock." }, { "title": "Golden Cross Forms in Windlas Biotech Ltd — On a Day the Stock Fell 1.42%. What the Mixed Signals Mean", "link": "https://www.marketsmojo.com/news/stocks-in-action/windlas-biotech-ltd-forms-golden-cross-signalling-potential-bullish-breakout-4104104", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/WindlasBiotechL_goldencross_4104104.png", "date": "2026-07-15 18:00:39", "description": "The 50-day moving average has crossed above the 200-day moving average for Windlas Biotech Ltd, signalling a golden cross on 15 Jul 2026. Yet, the stock declined 1.42% on the day the cross formed, while monthly technical indicators remain mildly bearish. This juxtaposition of signals calls for a detailed examination of the broader technical and fundamental context." }, { "title": "Windlas Biotech Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/windlas-biotech-ltd-is-rated-sell-4094995", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/WindlasBiotechL_mojoScore_4094995.png", "date": "2026-07-09 10:10:55", "description": "Windlas Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 July 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Windlas Biotech Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/windlas-biotech-ltd-is-rated-sell-4075837", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/WindlasBiotechL_mojoScore_4075837.png", "date": "2026-06-28 10:10:33", "description": "Windlas Biotech Ltd is rated Sell by MarketsMOJO, with this rating last updated on 05 Feb 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 28 June 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and technical outlook." } ], "total": 304, "sid": "1003519", "stock_news_url": "https://www.marketsmojo.com/news/windlas-biotech-1003519" }, "announcements": [ { "caption": "Board Meeting Intimation for Notice Of The Board Meeting Scheduled To Be Held On Monday August 10 2026", "datetime": "04-Aug-2026", "details": "Windlas Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 inter alia to consider and approve Notice is hereby given that pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 a meeting of the Board of Directors of the Company is scheduled to be held on Monday August 10 2026 inter alia to consider and approve the un-audited standalone financial results for the quarter ended June 30 2026.", "source": "BSE" }, { "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report", "datetime": "24-Jul-2026", "details": "Submission of Combined Voting Results and Scrutinizers Report under Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations) of the 25th Annual General Meeting held on July 23 2026", "source": "BSE" }, { "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report", "datetime": "24-Jul-2026", "details": "Submission of Combined Voting Results and Scrutinizers Report under Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations) of the 25th Annual General Meeting held on July 23 2026", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "", "data": [ { "title": "BOARD MEETING", "txt": "10 Aug 2026" } ] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Windlas Biotech Ltd has declared <strong>126%</strong> dividend, ex-date: 16 Jul 26", "dt": "2026-07-16", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

13 Jul: Stock opens strong at Rs.852.10 (+2.69%)

15 Jul: Golden Cross formation signals potential bullish breakout

16 Jul: Mojo Grade upgraded to Hold amid improving technicals

17 Jul: Week closes at Rs.844.80 (-0.56%)

Read full news article

Windlas Biotech Upgraded to Hold as Technicals Improve Amid Mixed Financials

2026-07-16 08:23:24

Windlas Biotech Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Sell to Hold as of 15 July 2026. This change reflects a nuanced improvement across technical indicators, valuation metrics, and financial trends, despite some lingering concerns over flat quarterly performance and modest long-term growth. The company’s current Mojo Score stands at 58.0, signalling a cautious but more optimistic outlook for investors.

Read full news article

Windlas Biotech Ltd Technical Momentum Shifts to Mildly Bullish Amid Mixed Indicators

2026-07-16 08:03:43

Windlas Biotech Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a mildly bullish outlook. This change is underscored by a combination of technical indicators, including MACD, RSI, moving averages, and Bollinger Bands, which collectively suggest a cautious but improving trend for the pharmaceutical and biotechnology small-cap stock.

Read full news article

Golden Cross Forms in Windlas Biotech Ltd — On a Day the Stock Fell 1.42%. What the Mixed Signals Mean

2026-07-15 18:00:39

The 50-day moving average has crossed above the 200-day moving average for Windlas Biotech Ltd, signalling a golden cross on 15 Jul 2026. Yet, the stock declined 1.42% on the day the cross formed, while monthly technical indicators remain mildly bearish. This juxtaposition of signals calls for a detailed examination of the broader technical and fundamental context.

Read full news article

Windlas Biotech Ltd is Rated Sell

2026-07-09 10:10:55

Windlas Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 July 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Windlas Biotech Ltd is Rated Sell

2026-06-28 10:10:33

Windlas Biotech Ltd is rated Sell by MarketsMOJO, with this rating last updated on 05 Feb 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 28 June 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and technical outlook.

Read full news article